J. B. Chemicals & Pharmaceuticals Limited

NSEI:JBCHEPHARM Voorraadrapport

Marktkapitalisatie: ₹269.5b

J. B. Chemicals & Pharmaceuticals Inkomsten in het verleden

Verleden criteriumcontroles 5/6

J. B. Chemicals & Pharmaceuticals is de winst gegroeid met een gemiddeld jaarlijks percentage van 13.5%, terwijl de Pharmaceuticals industrie de winst jaarlijks groeide met 13.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 17% per jaar. Het rendement op eigen vermogen van J. B. Chemicals & Pharmaceuticals is 19%, en het heeft een nettomarge van 16.5%.

Belangrijke informatie

13.5%

Groei van de winst

13.9%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie17.5%
Inkomstengroei17.0%
Rendement op eigen vermogen19.0%
Nettomarge16.5%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Sep 24
J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Aug 15
Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 11
J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Jun 28
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Apr 19
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03
J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21
A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15
Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29
Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Opbrengsten en kosten

Hoe J. B. Chemicals & Pharmaceuticals geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NSEI:JBCHEPHARM Opbrengsten, kosten en inkomsten (INR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 2437,1136,1118,5160
30 Jun 2435,9245,8718,2930
31 Mar 2434,8425,5268,1110
31 Dec 2333,8485,1417,6870
30 Sep 2333,3304,8667,5540
30 Jun 2332,6074,4717,4270
31 Mar 2331,4934,0987,2780
31 Dec 2230,1154,0716,5110
30 Sep 2228,1953,8486,3220
30 Jun 2226,0313,7156,0200
31 Mar 2224,2423,8545,6620
31 Dec 2123,2814,0114,9430
30 Sep 2122,7574,7134,5960
30 Jun 2121,2624,4744,3520
31 Mar 2120,4254,4804,2580
31 Dec 2019,5763,9754,2470
30 Sep 2018,3813,0974,2240
30 Jun 2018,5093,2954,1830
31 Mar 2017,7472,7204,0680
31 Dec 1917,5012,6864,0600
30 Sep 1917,0352,5213,9590
30 Jun 1916,8242,0983,9260
31 Mar 1916,4321,9353,8200
31 Mar 1814,0841,3833,2120
31 Mar 1713,4431,8412,7980
31 Mar 1612,1041,6252,2820
31 Mar 1511,4421,0042,1200
31 Mar 1410,2196153,0720

Kwaliteitswinsten: JBCHEPHARM heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (16.5%) JBCHEPHARM } zijn hoger dan vorig jaar (14.6%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van JBCHEPHARM is de afgelopen 5 jaar met 13.5% per jaar gegroeid.

Versnelling van de groei: De winstgroei van JBCHEPHARM over het afgelopen jaar ( 25.6% ) overtreft het 5-jarig gemiddelde ( 13.5% per jaar).

Winst versus industrie: De winstgroei JBCHEPHARM over het afgelopen jaar ( 25.6% ) overtrof de Pharmaceuticals -sector 20%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 19% ) van JBCHEPHARM wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden